Cargando…
Macrophage reprogramming for therapy
Dysfunction of the immune system underlies a plethora of human diseases, requiring the development of immunomodulatory therapeutic intervention. To date, most strategies employed have been focusing on the modification of T lymphocytes, and although remarkable improvement has been obtained, results o...
Autores principales: | Bart, Valentina M. T., Pickering, Robert J., Taylor, Philip R., Ipseiz, Natacha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114216/ https://www.ncbi.nlm.nih.gov/pubmed/33368269 http://dx.doi.org/10.1111/imm.13300 |
Ejemplares similares
-
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors
por: Ipseiz, Natacha, et al.
Publicado: (2020) -
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors
por: Ipseiz, Natacha, et al.
Publicado: (2019) -
Tissue‐resident macrophages actively suppress IL‐1beta release via a reactive prostanoid/IL‐10 pathway
por: Ipseiz, Natacha, et al.
Publicado: (2020) -
The Role of Macrophages During Zebrafish Injury and Tissue Regeneration Under Infectious and Non-Infectious Conditions
por: Bohaud, Candice, et al.
Publicado: (2021) -
The Role of Macrophages During Mammalian Tissue Remodeling and Regeneration Under Infectious and Non-Infectious Conditions
por: Bohaud, Candice, et al.
Publicado: (2021)